Activity value 72china Buyer&Supplier,Last transaction date:
2026-06-02
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for hubei haosun pharmacetical co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 9 transactions, with a transaction quantity of 10214.4 and a transaction weight of 0.
YearTransactionsQuantityWeight
2025109237.80
2026910214.40
Bill of lading data
<
1/15
>
Trade date
2026/06/02
B/L No.
108297822400
Suppliers
hubei haosun pharmacetical co.ltd.
Buyers
công ty cổ phần dược phẩm đạt vi phú
Product description
Nguyên liệu dược chất làm thuốc: Amisulpride; GPLH: VD-21204-14; HUBEI HAOSUN PHARMACEUTICAL CO., LTD.; Batch: HS4020240909 (NSX:9/2024-HD:9/2028); TC: EP11; hàng mới 100%
Expand
Trade date
2025/12/02
B/L No.
107759068800
Suppliers
hubei haosun pharmacetical co.ltd.
Buyers
công ty cổ phần dược phẩm đạt vi phú
hubei haosun pharmacetical co.ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as perindopril estrogen,sodium diacetyl benzoate,amisulpride.
According to the 52wmb.com global trade database, as of 2026-06-02, the company has completed 103 international trades,
with its main trading regions covering vietnam,russia,bangladesh etc.
The core products include HS29339990,HS29420090,HS29397900 etc,
often transported via hangzhou cn,port shanghai cn, port beijing cn etc,
and its main trading partners are công ty cổ phần dược trang thiết bị y tế bình định bidiphar,dat vi phu pharmaceutical joint sto,công ty cổ phần dược danapha.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on hubei haosun pharmacetical co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.